Abstract:Purpose of review: The purpose of this article is to review alterations in microbiota composition, diversity, and functional features in the context of chronic inflammation and comorbidities associated with HIV infection. Recent findings: The gut microbiome is an important mediator of host immunity, and disruption of gut homeostasis can contribute to both systemic inflammation and immune activation. Ageing and HIV share features of intestinal damage, microbial translocation and alterations in bacterial composition that contribute to a proinflammatory state and development of age-related comorbidities. One such inflammatory pathway reviewed is the nicotinamide adenine dinucleotide (NAD+) producing kynurenine pathway (KP). Kynurenine metabolites regulate many biological processes including host-microbiome communication, immunity and oxidative stress and the KP in turn is influenced by the microbiome environment. Age-associated decline in NAD+ is implicated as a driving factor in many age-associated diseases, including those seen in people with HIV (PWH). Recent studies have shown that KP can influence metabolic changes in PWH, including increased abdominal adiposity and cardiovascular disease. Furthermore, KP activity increases with age in the general population, but it is elevated in PWH at all ages compared to age-matched controls. Host or microbiome-mediated targeting of this pathway has merits to increase healthy longevity and has potential therapeutic applications in PWH. Summary: As a growing proportion of PWH age, many face increased risks of developing age-related comorbidities. Chronic inflammation, a pillar of geroscience, the science of ageing and of age-related disease, is influenced by the gut microbiome and its metabolites. Combined, these contribute to a systemic inflammatory signature. Advances in geroscience-based approaches and therapeutics offer a novel paradigm for addressing age-related diseases and chronic inflammation in HIV infection. Whether targeted inhibition of KP activity alleviates pathological conditions or promotes successful ageing in PWH remains to be determined.

HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway

What is the collective effect of aging and HIV on the gut microbiome?

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

Aging With Grace for People Living With HIV: Strategies to Overcome Leaky Gut and Cytomegalovirus Coinfection

The Gut and the Translocated Microbiomes in HIV Infection: Current Concepts and Future Avenues

Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection

Review on the alteration of gut microbiota: the role of HIV infection and old age.

HIV and Gut Microbiota: Understanding the Link between Immune Function, Inflammation, and Viral Persistence

Regulation of Immune Homeostasis, Inflammation, and HIV Persistence by the Microbiome, Short-Chain Fatty Acids, and Bile Acids

Altered gut microbiome composition in HIV infection: causes, effects and potential intervention

Accelerated Aging process in Patients Living with HIV: Role of Mitochondrial Dysfunction.

Cardiac and Renal Comorbidities in Aging People Living With HIV

A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.

Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV

Therapeutic microbiome modulation: new frontiers in HIV treatment

Among Older Adults, Age-Related Changes in the Stool Microbiome Differ by HIV-1 Serostatus.

HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration

Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don't

Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies

A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

The pathogenesis of obesity in people living with HIV